株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

甲状腺機能検査の世界市場:成長、動向、予測(2020~2025年)

Thyroid Function Test Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 824074
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=113.11円で換算しております。
Back to Top
甲状腺機能検査の世界市場:成長、動向、予測(2020~2025年) Thyroid Function Test Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年01月01日 ページ情報: 英文 110 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

世界の甲状腺機能検査市場は、2024年にかけげCAGR6%で拡大するとみられています。この成長を促進しているのが、甲状腺疾患の発症率上昇、タバコやアルコールの消費増加、座りっぱなしの生活習慣などです。

当レポートでは、世界の甲状腺機能検査市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場動向

  • 市場概要
  • 市場促進因子
    • 甲状腺疾患の発症率上昇
    • タバコやアルコールの消費増加
    • 座りっぱなしの生活習慣
  • 市場阻害因子
    • 甲状腺血液検査の解釈に伴う問題
    • 内分泌学専門家の不足
  • ポーターズファイブフォース分析

第5章 市場セグメンテーション

  • 検査別
    • TSH
    • T4
    • T3
    • その他
  • エンドユーザー別
    • 病院
    • 診断試験所
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合動向

  • 企業プロファイル
    • Abbott
    • Autobio Diagnostics
    • bioMerieux SA
    • Danaher Corporation
    • DiaSorin SpA
    • F. Hoffmann-La Roche Ltd
    • Qualigen Inc.
    • Quidel Corporation
    • Siemens Healthineers
    • Thermo Fisher Scientific Inc.

第7章 市場の機会と将来動向

目次
Product Code: 64540

Market Overview

The thyroid function test market is expected to witness a CAGR of 6% during the forecast period. Certain factors that are driving the growth of the market include rising incidence of thyroid disorders, increasing consumption of tobacco and alcohol, and sedentary lifestyle.

Thyroid diseases have become a significant public health concern across the world. The risk factors include genetic background, environmental exposures, insufficient iodine intake, exposure to polychlorinated biphenyls, radiation from nuclear fallout and medical radiation, and alcohol and tobacco consumption, among others. As per the American Thyroid Association, approximately 20 million US citizens have some form of thyroid disease (2017). The thyroid function test market is witnessing substantial growth due to the high prevalence of thyroid disorder, as well as due to the rising consumption of alcohol and tobacco.

Alcohol consumption is considered to be one of the most significant risk factors for disease and disability. Globally, high-income countries of the developed regions have the highest alcohol consumption, with 50.1% of the US population (adults over 18 years of age) being regular drinkers. As per various studies, there is a negative relationship between the hypothalamic-pituitary-thyroid (HPT) axis and alcoholism. Regular drinking inhibits the peripheral thyroid hormones, frees T3 and T4, and reduces the activity of type II 5'-deiodinase, which further affects the metabolic function, leading to the development of hypothyroidism. Tobacco also induces changes in thyroid function tests, such as the decrease in TSH and increase in thyroid hormones.

Furthermore, tobacco smoking plays a crucial role in thyroid autoimmunity. A few research studies confirmed the significant effect of smoking on Graves' hyperthyroidism, particularly on Graves' orbitopathy. Other factors contributing to the growth of the thyroid function test market are the rising incidence of thyroid disorders and a sedentary lifestyle.

However, the shortage in endocrinologists is expected to limit the growth of the thyroid function test market. Endocrinologists play a pivotal role in treating patients with some of the most complex and prevalent conditions faced in the United States today. At present, fewer than 6,500 endocrinologists are available in the country to provide care for the millions of patients who have diabetes, thyroid disease, osteoporosis, and other hormonal conditions. Even the compensation for endocrinologists is the lowest of any internal medicine specialty, which is predicted to harm the growth of the thyroid function test market. Another factor contributing to the slow growth of the thyroid function test market is the difficulty associated with the interpretation of thyroid blood tests.

Scope of the Report

Thyroid function tests are a series of blood tests used to determine the condition of the thyroid gland, whether it is working properly, and diagnosing hyperthyroidism and hypothyroidism. The general tests include the tests for T3, T3RU, T4, and TSH hormones (secreted by thyroid glands), which measure the activities of the thyroid gland.

Key Market Trends

TSH Test is Expected to Hold the Largest Market Share in the Test Type

TSH measurement has recently gained a dominant role in thyroid function testing, further facilitating cost-effective disease screening, and also introducing new definitions of subclinical hypothyroidism or hyperthyroidism, along with delivering biochemical treatment targets. TSH (thyroid stimulating hormone) test measures how much of this hormone is in a patient's blood. The test finds out whether the thyroid gland is working the way it should. It is very little to no risk in taking the blood test. The slight pain or bruising at the spot where the needle was put in goes away quickly.

However, A TSH test cannot explain why TSH levels are too low or too high. If the test results are abnormal, the healthcare provider generally orders additional tests to determine the cause of the thyroid problem. These tests may include T4 thyroid hormone tests, T3 thyroid hormone tests, tests to diagnose Graves' disease (an autoimmune disease that causes hyperthyroidism), or tests to diagnose Hashimoto's thyroiditis (an autoimmune disease that causes hypothyroidism).

North America Dominates the Market and Expected to Keep its Position in the Forecast Period

Based on the geographical analysis, North America is predicted to lead the thyroid function test market, owing to the prevalence of thyroid cancer in the United States. As per the National Cancer Institute, in 2015, there were around 765,547 people living with thyroid cancer in the United States and the number of new cases of thyroid cancer was 14.5 per 100,000 men and women per year.

The North American region is also likely to witness a major growth, owing to several initiatives such as the compulsory screening of newborns for congenital hypothyroidism, revolutionary research work on thyroid hormone function, cost-effective methods to detect thyroid cancer, promising research on Graves' disease, etc., which may further lead to improved prognosis and new preventive treatments of thyroid diseases.

Competitive Landscape

The thyroid function test market, which is highly competitive, consists of a number of major players. Companies, such as Abbott, Autobio Diagnostics, BioMerieux SA, Danaher Corporation, DiaSorin SpA, F. Hoffmann-La Roche Ltd, Qualigen Inc., Qualigen Inc., Siemens Healthineers, and Thermo Fisher Scientific Inc., among others, hold a substantial market share in the thyroid function test market.

Recently, various developments have been taking place in the market. For instance, in May 2018, Interpace Diagnostics Group reported that the company entered into an agreement with the Vanderbilt University Medical Center (VUMC), which would enable all physicians across the Vanderbilt system to gain access to both ThyGenX(R) (now ThyGeNEXT(R)) and ThyraMIR(R) for patients with indeterminate thyroid nodules.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Thyroid Disorders
    • 4.2.2 Increasing Consumption of Tobacco and Alcohol
    • 4.2.3 Sedentary Lifestyle
  • 4.3 Market Restraints
    • 4.3.1 Problems associated with Interpretation of Thyroid Blood Tests
    • 4.3.2 Shortage of Endocrinologists
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Test
    • 5.1.1 TSH Test
    • 5.1.2 T4 Test
    • 5.1.3 T3 Test
    • 5.1.4 Other Tests
  • 5.2 End User
    • 5.2.1 Hospital
    • 5.2.2 Diagnostic Laboratory
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Autobio Diagnostics
    • 6.1.3 bioMerieux SA
    • 6.1.4 Danaher Corporation
    • 6.1.5 DiaSorin SpA
    • 6.1.6 F. Hoffmann-La Roche Ltd
    • 6.1.7 Qualigen Inc.
    • 6.1.8 Quidel Corporation
    • 6.1.9 Siemens Healthineers
    • 6.1.10 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top